However, there is strong evidence to suggest that clusterin protein interacts with a number of other AD-relevant proteins including the main AD pathological proteins such as tau and Aβ, as well as AD risk factors such as APOE and BIN1. Although these interactions have been observed at a biological level, the influence of genetic variants in CLU on these interactions remains elusive. Here, MAPT is linked to Alzheimer disease.